Skip to main content
EDX Medical Group Plc logo

EDX Medical Group Plc — Investor Relations & Filings

Ticker · EDX ISIN · GB00BNDMJS47 LEI · 213800BZVJZTMCZ6DJ63 Aquis Stock Exchange Human health and social work activities
Open in API
Filings indexed 116 across all filing types
Latest filing 2023-05-26 Regulatory Filings
Country GB United Kingdom
Listing Aquis Stock Exchange EDX

About EDX Medical Group Plc

https://edxmedical.com/

EDX Medical Group Plc develops and provides digital diagnostic products and services for healthcare professionals. Its solutions are designed for the rapid detection and characterization of major diseases, enabling personalized treatment and improved patient outcomes. The company's primary focus areas are oncology, cardiology, and infectious diseases. Key offerings in oncology include comprehensive tumour profiling using whole exome and transcriptome sequencing, liquid biopsy analysis, and functional ex vivo assays that predict tumour response to specific therapies. The company also develops highly sensitive tests for early detection of cancers such as prostate and testicular cancer. In infectious diseases, EDX Medical develops point-of-care multiplex tests for conditions like sepsis and pneumonia. The company's approach integrates advanced molecular biology, genomic sequencing, and digital technologies across its laboratory-based services and point-of-care devices.

Recent filings

Filing Released Lang Actions
EDX Medical Group Plc - Strategic investment from Seerave Enterprises Ltd
Regulatory Filings Classification · 95% confidence The document is an announcement from EDX Medical Group Plc regarding a strategic investment of £350,000 from Seerave Enterprises Ltd, involving the issuance of 4,375,000 new ordinary shares. It details the subscription, the purpose of the funds, and includes a 'Total Voting Rights' disclosure as required by the Financial Conduct Authority. Since the document describes a new share issuance and capital change, it falls under the 'Share Issue/Capital Change' category.
2023-05-26 English
EDX Medical Group Plc - Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a formal announcement regarding 'Total Voting Rights' issued by EDX Medical Group Plc in accordance with the Financial Conduct Authority's Disclosure and Transparency Rules. It specifies the total number of ordinary shares and voting rights to assist shareholders in calculating their notification requirements. This type of regulatory disclosure regarding share capital and voting rights is standard for RNS (Regulatory News Service) filings.
2023-04-28 English
EDX Medical Group Plc - Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a standard TR-1 form, which is the official regulatory template used in the UK for notifying major shareholding changes (crossing thresholds). It explicitly identifies the issuer (EDX Medical Group plc), the person subject to the notification (Bridgemere Securities Ltd), and the percentage of voting rights held (11.63%). This fits the definition of a Major Shareholding Notification (MRQ).
2023-04-26 English
EDX Medical Group Plc - Placing to raise £1,725,000
Share Issue/Capital Change Classification · 100% confidence The document is an announcement by EDX Medical Group Plc regarding a capital raise of £1,725,000 through the issuance of 28,750,000 new ordinary shares. It details the placing, the investors involved, and the subsequent impact on total voting rights. This falls under the category of share issuance and capital changes.
2023-04-26 English
EDX Medical Group Plc - Director Dealing
Director's Dealing Classification · 100% confidence The document is titled 'Director Dealing' and explicitly details a share purchase transaction by a person discharging managerial responsibilities (PDMR), specifically the Non-executive Chairman, Jason Holt. It includes the required regulatory disclosure format for such transactions, including the name of the person, the nature of the transaction, the price, and the volume of shares purchased. This aligns perfectly with the definition of a Director's Dealing (DIRS) filing.
2023-03-13 English
EDX Medical Group Plc - Total Voting Rights Correction
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement regarding 'Total Voting Rights' issued by EDX Medical Group Plc in accordance with the Financial Conduct Authority's Disclosure and Transparency Rules. It specifies the total number of ordinary shares and voting rights to assist shareholders with regulatory notification requirements. This type of disclosure is a standard regulatory filing regarding share capital and voting rights, which does not fit into specific categories like 'Major Shareholding Notification' (which is for external investors) or 'Share Issue' (which is for the act of issuance itself). Therefore, it falls under the general regulatory filing category.
2023-03-01 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.